Filing Flows

Filing Flows › LivaNova (LIVN) › Q1 2025

LivaNova (LIVN) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 7, 2025

LivaNova (LIVN) reported revenue of $317M for the first quarter 2025 (Q1 2025), +7% from a year earlier and -2% from the quarter before. Operating margin was 15.3%, net loss $327M (103.3% of revenue).

Revenue$317M
Year over year+7%
Quarter over quarter-2%
Operating margin15.3%
Net earnings−$327M

LivaNova, Q1 2025: revenue $317M (+7% year over year), operating margin 15.3%, net loss $327M, operating cash flow $24.0M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$317M-2%+7%
Operating profit$48.6M——
Net earnings−$327M——
Operating cash flow$24.0M-70%+140%
Free cash flow$20.1M——

What changed

Revenue was $316.9M in Q1 2025, up 7% year over year and down 2% from the previous quarter.

Gross margin was 68.3%, down 0.7 points from a year earlier. Operating profit was $48.6M, a 15.3% margin (up 9.8 points year over year). Of the extra revenue versus a year earlier, 148% reached operating profit, above the 6% margin then. Operating expenses fell 10% while revenue rose 7%. The quarter ended with a net loss of $327.3M, after a profit of $55.9M the previous quarter. Net interest and other expense of $364.3M was the main reason.

Operating cash flow was $24.0M (up 140% year over year). Non-cash charges added back $10.6M of depreciation and amortization and $7.8M of share-based compensation. Working capital and other items added $332.9M. After purchases of plant, property, and equipment, net ($3.8M) and cybersecurity incident insurance proceeds ($100K), adjusted free cash flow as the company reports it was $20.1M.

Questions

What was LivaNova's revenue in the first quarter 2025?

LivaNova (LIVN) reported revenue of $317M for the first quarter 2025 (Q1 2025), +7% from a year earlier and -2% from the quarter before.

Was LivaNova profitable in the first quarter 2025?

Operating profit was $48.6M (15.3% of revenue) and net loss $327M.

Open the interactive Sankey →

Source: LivaNova 10-Q on SEC EDGAR.